ACCESS Newswire
22 Feb 2021, 19:43 GMT+10
HACKENSACK, NJ / ACCESSWIRE / February 22, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR) a leading global oncology technology solutions provider transforming drug discovery through innovative pharmacology, biomarker, and data platforms, is pleased to announce the appointment of Rob Brainin to its Board of Directors. Rob is an experienced global life sciences and healthcare executive with more than 15 years of experience. His appointment will help guide the company's efforts to accelerate the development of its data platform for use in drug discovery. The Company also announced the resignation of current board member Abba Poliakoff.
Joel Ackerman, Chairman of the Board of Directors commented, 'We are excited to have Rob join our Board of Directors. Rob has spent his career at the nexus of life science data and technology, and has leveraged his depth and breadth to become a leader in the use of genomic data to drive drug development. We expect his unique experience will be invaluable in helping us capitalize on our technology platform and evolve our strategy.' Ackerman added, 'We deeply appreciate Abba's many contributions to the development of Champions. He has been a valuable resource and advisor to the company during his many years of service.'
Rob recently was the Chief Executive Officer of Genuity Science where he focused on ways to transform clinical and molecular data into real-life solutions, making complex multi-omic information actionable for global communities in their quest to improve healthcare. Before joining Genuity, Rob was Vice President and General Manager of Life Sciences and Applied Genomics at Illumina, having previously served as VP and Head of the Arrays Business. Rob has also held senior roles at Life Technologies, Invitrogen and Thermo Fisher. In all these roles, he led the expansion of the applications of technologies or genomic data to new fields to serve the needs of growing types of users. Rob holds an undergraduate degree in economics from Emory University and a law degree from Harvard Law School. He currently serves on the Board of Directors of The Children's Tumor Foundation.
Media Contact:
Rachel Bunting, MS, MBA
Sr. Director, Head of Marketing
[email protected]
SOURCE: Champions Oncology, Inc.
Get a daily dose of Miami Mirror news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Miami Mirror.
More InformationLONDON, U.K.: This week, BP appointed Simon Henry, former Shell finance chief, to its board as a non-executive director effective September...
OTTAWA, Canada: With Canada Post struggling to maintain operations amid labour unrest, rivals like FedEx and UPS are stepping in to...
NEW YORK, New York - U.S. and global markets showed a mixed performance in Tuesday's trading session, with some indices edging higher...
PARIS, France: French military and intelligence officials have accused China of orchestrating a covert campaign to damage the reputation...
NEW DELHI, India: Birkenstock is stepping up its efforts to protect its iconic sandals in India, as local legal representatives conducted...
HONG KONG: China has fired back at the European Union in an escalating trade dispute by imposing new restrictions on medical device...
MOSCOW, Russia: Just hours after his sudden dismissal by President Vladimir Putin, Russia's former transport minister, Roman Starovoit,...
DHARAMSHALA, India: The Dalai Lama turned 90 on July 6, celebrated by thousands of followers in the Himalayan town of Dharamshala,...
ZAGREB, Croatia: A massive concert by popular Croatian singer Marko Perković, known by his stage name Thompson, has drawn widespread...
WASHINGTON, D.C.: Elon Musk's entry into the political arena is drawing pushback from top U.S. officials and investors, as his decision...
CULVER CITY, California: TikTok is preparing to roll out a separate version of its app for U.S. users, as efforts to secure a sale...
WASHINGTON, D.C.: President Donald Trump claimed he was unaware that the term shylock is regarded as antisemitic when he used it in...